Precipio, Inc. (PRPO)
NASDAQ: PRPO · Real-Time Price · USD
5.27
-0.18 (-3.30%)
Dec 20, 2024, 4:00 PM EST - Market closed
Precipio Employees
As of December 31, 2023, Precipio had 57 total employees, including 51 full-time and 6 part-time employees. The number of employees increased by 1 or 1.79% compared to the previous year.
Employees
57
Change (1Y)
1
Growth (1Y)
1.79%
Revenue / Employee
$305,456
Profits / Employee
-$52,632
Market Cap
7.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
XWELL | 337 |
Evogene | 142 |
Mustang Bio | 80 |
Soligenix | 15 |
COSCIENS Biopharma | 12 |
CERo Therapeutics Holdings | 9 |
Portage Biotech | 7 |
Ensysce Biosciences | 7 |
PRPO News
- 4 weeks ago - Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Precipio Announces Q3-2024 Shareholder Update Call - GlobeNewsWire
- 2 months ago - Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping - GlobeNewsWire
- 3 months ago - Precipio Announces Employee Stock Option Plan Repricing - GlobeNewsWire
- 4 months ago - Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Precipio Announces Q2-2024 Shareholder Update Call - GlobeNewsWire
- 5 months ago - Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven - GlobeNewsWire
- 5 months ago - Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 - GlobeNewsWire